| 臺大學術典藏 |
2020-11-27T03:25:24Z |
Prevention of acute kidney injury by low intensity pulsed ultrasound via anti-inflammation and anti-apoptosis
|
Chiang C.-K.;Loh J.-Z.;Yang T.-H.;Huang K.-T.;Wu C.-T.;Guan S.-S.;Liu S.-H.;Kuan-Yu Hung; Chiang C.-K.; Loh J.-Z.; Yang T.-H.; Huang K.-T.; Wu C.-T.; Guan S.-S.; Liu S.-H.; KUAN-YU HUNG |
| 臺大學術典藏 |
2020-11-27T03:25:13Z |
Chemical chaperon 4-phenylbutyrate protects against the endoplasmic reticulum stress-mediated renal fibrosis in vivo and in vitro
|
Liu S.-H.; Yang C.-C.; Chan D.-C.; Wu C.-T.; Chen L.-P.; Huang J.-W.; KUAN-YU HUNG; Chiang C.-K. |
| 臺大學術典藏 |
2020-11-27T03:25:07Z |
Endoplasmic reticulum stress implicated in the development of renal fibrosis
|
Chiang C.-K.;Hsu S.-P.;Wu C.-T.;Huang J.-W.;Cheng H.-T.;Chang Y.-W.;Kuan-Yu Hung;Wu K.-D.;Liu S.-H.; Chiang C.-K.; Hsu S.-P.; Wu C.-T.; Huang J.-W.; Cheng H.-T.; Chang Y.-W.; KUAN-YU HUNG; Wu K.-D.; Liu S.-H. |
| 臺大學術典藏 |
2020-11-27T03:24:46Z |
Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro
|
Chiang C.-K.; Sheu M.-L.; Lin Y.-W.; Wu C.-T.; Yang C.-C.; Chen M.-W.; KUAN-YU HUNG; Wu K.-D.; Liu S.-H.; Chiang C.-K.;Sheu M.-L.;Lin Y.-W.;Wu C.-T.;Yang C.-C.;Chen M.-W.;Kuan-Yu Hung;Wu K.-D.;Liu S.-H. |
| 臺大學術典藏 |
2020-11-27T03:24:38Z |
CCAAT-Enhancer-Binding Protein Homologous Protein Deficiency Attenuates Oxidative Stress and Renal Ischemia-Reperfusion Injury
|
Chen B.L.; Sheu M.L.; Tsai K.S.; Lan K.C.; Guan S.S.; Wu C.T.; Chen L.P.; KUAN-YU HUNG; Huang J.W.; Chiang C.K.; Liu S.H. |
| 臺大學術典藏 |
2020-11-19T03:20:03Z |
Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer
|
Liang J.-T.; Lai H.-S.; Wu C.-T.; Huang K.-C.; PO-HUANG LEE; Shun C.-T. |
| 臺大學術典藏 |
2020-11-17T02:45:34Z |
Comparisons and performance evaluations of RNA-seq alignment tools
|
Wang W.-A.;Wu C.-T.;Tzu-Pin Lu;Tsai M.-H.;Lai L.-C.;Chuang E.Y.; Wang W.-A.; Wu C.-T.; TZU-PIN LU; Tsai M.-H.; Lai L.-C.; Chuang E.Y. |
| 臺大學術典藏 |
2020-11-03T15:39:27Z |
Erratum: Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases (Oral Oncology (2015) 51: 5 (493-499))
|
Chang Y.-L.; Ko J.-Y; Lou P.-J; Chen T.-C; Wu C.-T; CHENG-PING WANG; Yang T.-L |
| 臺大學術典藏 |
2020-11-03T15:39:27Z |
Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases
|
Yang T.-L; Lou P.-J; Ko J.-Y; Chang Y.-L.; Wu C.-T; CHENG-PING WANG; Chen T.-C |
| 臺大學術典藏 |
2020-11-03T15:39:23Z |
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
|
Ko J.-Y; Wu C.-T; Chang Y.-L.; Chen T.-C; Chen C.-H; CHENG-PING WANG; Lin P.-H; Yang T.-L; Lou P.-J |
| 臺大學術典藏 |
2020-11-03T15:39:23Z |
The Pretreatment Neutrophil-to-Lymphocyte Ratio is a Prognostic Determinant of T3?? Hypopharyngeal Squamous Cell Carcinoma
|
Ko J.-Y; Chang Y.-L.; Lo W.-C; Wu C.-T; CHENG-PING WANG; Yang T.-L; Lou P.-J |
| 臺大學術典藏 |
2020-11-03T15:39:23Z |
Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer
|
Lo W.-C; Wu C.-T; CHENG-PING WANG; Yang T.-L; Lou P.-J; Ko J.-Y; Chang Y.-L. |
| 臺大學術典藏 |
2020-11-03T15:39:17Z |
The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer
|
Chang Y.-L.; Ko J.-Y; Lou P.-J; CHENG-PING WANG; Wu C.-T; Chen T.-C |
| 臺大學術典藏 |
2020-11-03T15:39:17Z |
Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region
|
Chen T.-C; Wu C.-T; Ko J.-Y; Yang T.-L; Lou P.-J; CHENG-PING WANG; Chang Y.-L. |
| 臺大學術典藏 |
2020-11-02T02:05:32Z |
Obstructive jaundice caused by hepatocellular carcinoma: Detection by endoscopic sonography
|
Lee Y.-C.; Wang H.-P.; Huang S.-P.; Chang Y.-T.; Wu C.-T.; Yang C.-S.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-10-27T12:04:33Z |
Tumor satellite in predicting occult nodal metastasis of tongue cancer
|
Ko J.-Y.; Wang C.-P; Wu C.-T; PEI-JEN LOU; Chang Y.-L; Yang T.-L; Yang T.-L;Pei-Jen Lou;Chang Y.-L;Wu C.-T;Wang C.-P;Ko J.-Y. |
| 臺大學術典藏 |
2020-10-27T12:04:23Z |
Erratum: Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases (Oral Oncology (2015) 51: 5 (493-499))
|
Chen T.-C; Wu C.-T; Wang C.-P; Yang T.-L; PEI-JEN LOU; Ko J.-Y; Chang Y.-L. |
| 臺大學術典藏 |
2020-10-27T12:04:23Z |
Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases
|
Chen T.-C; PEI-JEN LOU; Ko J.-Y; Chang Y.-L.; Yang T.-L; Wu C.-T; Wang C.-P |
| 臺大學術典藏 |
2020-10-27T12:04:16Z |
The pretreatment neutrophil to lymphocyte ratio is a prognostic determinant of T3-4 hypopharyngeal squamous cell carcinoma
|
Lo W.-C; Wu C.-T; Wang C.-P; Yang T.-L; PEI-JEN LOU; Ko J.-Y; Chang Y.-L. |
| 臺大學術典藏 |
2020-10-27T12:04:16Z |
Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer
|
Lo W.-C;Wu C.-T;Wang C.-P;Yang T.-L;Pei-Jen Lou;Ko J.-Y;Chang Y.-L.; Lo W.-C; Wu C.-T; Wang C.-P; Yang T.-L; PEI-JEN LOU; Ko J.-Y; Chang Y.-L. |
| 臺大學術典藏 |
2020-10-27T12:04:08Z |
Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region
|
Chen T.-C;Wu C.-T;Ko J.-Y;Yang T.-L;Pei-Jen Lou;Wang C.-P;Chang Y.-L.; Chen T.-C; Wu C.-T; Ko J.-Y; Yang T.-L; PEI-JEN LOU; Wang C.-P; Chang Y.-L. |
| 國立交通大學 |
2020-10-05T02:01:28Z |
First Demonstration of CMOS Inverter and 6T-SRAM Based on GAA CFETs Structure for 3D-IC Applications
|
Chang, S. -W.; Sung, P. -J.; Chu, T-Y.; Lu, D. D.; Wang, C. -J.; Lin, N. -C.; Su, C. -J.; Lo, S. -H.; Huang, H. -F.; Li, J. -H.; Huang, M. -K.; Huang, Y. -C.; Huang, S. -T.; Wang, H. -C.; Huang, Y. -J.; Wang, J. -Y.; Yu, L. -W; Huang, Y. -F.; Hsueh, F. -K.; Wu, C. -T.; Ma, W. C. -Y.; Kao, K. -H.; Lee, Y. -J.; Lin, C. -L.; Chuang, R. W.; Huang, K. -P.; Samukawa, S.; Li, Y.; Lee, W. -H.; Chao, T. -S.; Huang, G. -W.; Wu, W. -F.; Li, J. -Y.; Shieh, J. -M.; Yeh, W. -K.; Wang, Y. -H. |
| 臺大學術典藏 |
2020-09-30T03:23:28Z |
Hepatic leiomyomatous neoplasm associated with Epstein Barr virus infection in an adult with acquired immunodeficiency syndrome
|
CHIEN-CHING HUNG; Wu C.-T.; Wang M.-H.;Wu C.-T.;Chien-Ching Hung;Liang J.-D.;Chen P.-J.; Wang M.-H.; Liang J.-D.; Chen P.-J. |
| 臺大學術典藏 |
2020-09-30T03:23:22Z |
Cervical tuberculous lymphadenitis as the main symptom before HIV seropositive status is confirmed - Report of four cases
|
Chiu T.-J.; Chiu T.-J.;Sheen T.-S.;Wu C.-T.;Chien-Ching Hung; Sheen T.-S.; Wu C.-T.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-23T06:22:30Z |
Asymmetric intense bilateral adrenal uptake on [ 18F] fluorodeoxyglucose positron emission tomography/computed tomography in a patient with solitary pulmonary nodule
|
Cheng M.-F.; Lin M.-W.; Wu C.-T.; Shih S.-R.; Wu Y.-W.; Tzen K.-Y.; RUOH-FANG YEN |
| 臺大學術典藏 |
2020-08-13T06:34:11Z |
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas
|
Lee Y.-C.; JIN-YUAN SHIH; Wu C.-T.; Chang Y.-L.; Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
|
JIN-YUAN SHIH; Wu C.-T.; Lee Y.-C.; Lee Y.-C.;Wu C.-T.;Jin-Yuan Shih;Jou Y.-S.;Chang Y.-L.; Jou Y.-S.; Chang Y.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:07Z |
The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers
|
Wu C.-T.;Chang Y.-L.;Jin-Yuan Shih;Lee Y.-C.; Wu C.-T.; Chang Y.-L.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:05Z |
Estrogen receptor β - Which one and where should we draw the line - Reply [2]
|
Wu C.-T.; Chang Y.-L.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:59Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:54Z |
Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers
|
Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:54Z |
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
|
Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:52Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:51Z |
EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy
|
Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:50Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:48Z |
The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction
|
Lee Y.-C.; Wu C.-T.; JIN-YUAN SHIH; Lin M.-W.; Chang Y.-L.;Lin M.-W.;Jin-Yuan Shih;Wu C.-T.;Lee Y.-C.; Chang Y.-L. |
| 臺大學術典藏 |
2020-08-13T06:33:45Z |
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimension
|
Lin M.-W.; Wu C.-T.; JIN-YUAN SHIH; Chang Y.-L.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Shang-Gin Wu ;Chang Y.-L. ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; SHANG-GIN WU; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:35:35Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:15Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F. |
| 臺大學術典藏 |
2020-07-21T06:09:18Z |
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms
|
Chang Y.-L.;Lee Y.-C.;Wei-Yu Liao;Wu C.-T.; Chang Y.-L.; Lee Y.-C.; WEI-YU LIAO; Wu C.-T. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:34Z |
Programmed cell death-ligand 1 expression in surgically resected stage i pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
|
Yang P.-C.; Wu C.-T.; Chang Y.-L.; Lin M.-W.; CHING-YAO YANG; Ching-Yao Yang;Lin M.-W.;Chang Y.-L.;Wu C.-T.;Yang P.-C. |
